--Five Star Bancorp Keeps Quarterly Dividend at $0.20 a Share, Payable Nov. 12 to Shareholders of Record Nov. 4-July 2024-www.financetom.com

--Five Star Bancorp Keeps Quarterly Dividend at $0.20 a Share, Payable Nov. 12 to Shareholders of Record Nov. 4

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Five Star Bancorp Keeps Quarterly Dividend at $0.20 a Share, Payable Nov. 12 to Shareholders of Record Nov. 4

Oct 18, 2024 10:34 AM

01:12 PM EDT, 10/18/2024 (MT Newswires) --

Price: 31.05, Change: -0.25, Percent Change: -0.80

Previous page： Critical Metals to raise $50 million PIPE financing Next page： MGM Resorts to Sell MGM Northfield Park Operations to Clairvest for $546 Million

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Critical Metals to raise $50 million PIPE financing

Oct 16, 2025

Oct 16 (Reuters) - Critical Metals said on Thursday it will raise $50 million through a private investment in public equity (PIPE) deal with an institutional investor to fund development of its Tanbreez rare earth deposit in Greenland. ...

MGM Resorts to Sell MGM Northfield Park Operations to Clairvest for $546 Million

Oct 16, 2025

08:12 AM EDT, 10/16/2025 (MT Newswires) -- MGM Resorts International ( MGM ) said Thursday that it agreed to sell the operations of MGM Northfield Park racetrack and casino in Northfield, Ohio for $546 million in cash to private equity funds managed by Clairvest Group. When the deal closes, which is expected in H1 of 2026, MGM Resorts' ( MGM...

Top Premarket Gainers

Oct 16, 2025

08:07 AM EDT, 10/16/2025 (MT Newswires) -- Praxis Precision Medicines ( PRAX ) shares were 170% higher pre-bell Thursday after the company reported that its investigational drug ulixacaltamide in essential tremor helped improve patients' daily functioning in two late-stage trials. Cellectis ( CLLS ) stock was up 20% following a 1.4% loss in the previous session. JB Hunt Transport Services...

C4 Therapeutics Prices $125 Million Underwritten Offering; Shares Fall Pre-Bell

Oct 16, 2025

08:09 AM EDT, 10/16/2025 (MT Newswires) -- C4 Therapeutics ( CCCC ) said Thursday it priced an underwritten offering of about 21.9 million common shares at $2.47 per share and pre-funded warrants to purchase up to 28.7 million common shares at $2.4699 per warrant. Each common share and pre-funded warrant are being sold together with class A and class B...